In Vivo Efficacy CROs for Non-human Primate Studies

Showing 13 CROs. Order rotates daily so no lab is permanently listed first.

ZSHK Laboratories

HK GLP

Preclinical CRO with roots in a Chinese Academy of Sciences safety center, offering pharmacology, DMPK and safety evaluation with GLP operations in Shenzhen.

In Vivo Efficacy Pharmacokinetics Toxicology Non-human Primate Rat

Kunming Biomed International (KBI)

CN AAALAC

Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.

In Vivo Efficacy Pharmacokinetics Toxicology Non-human Primate

Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…

In Vivo Efficacy AAV Biodistribution Bioanalysis Bioavailability Studies Biodistribution Non-human Primate Cynomolgus monkey Minipig Mouse

Texas Biomedical Research Institute

US GLP

Independent nonprofit research institute with a national primate research center and high-containment labs, offering contract infectious disease, vaccine and NHP studies.

In Vivo Efficacy Infectious Disease Models Toxicology Vaccine Development Non-human Primate Cynomolgus monkey Mouse Rhesus monkey

Alpha Genesis

US GLP AAALAC

Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.

In Vivo Efficacy Gene Therapy Studies GLP Toxicology Pharmacokinetics Vaccine Development Non-human Primate Cynomolgus monkey Mouse Rat

PharmaLegacy Laboratories

CN GLP AAALAC

Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.

In Vivo Efficacy Bone & Joint Models Inflammation Models Metabolic Disease Models Oncology Models Non-human Primate Dog Mouse Rabbit

Tulane National Primate Research Center

US GLP AAALAC

National primate research center with high-containment capability supporting infectious disease, vaccine and translational NHP studies, including sponsored research.

In Vivo Efficacy Infectious Disease Models Vaccine Development Non-human Primate Rhesus monkey

Hamamatsu Pharma Research

JP AAALAC

AAALAC-accredited Japanese CRO specializing in nonhuman primate disease models for preclinical efficacy and proof of concept.

In Vivo Efficacy CNS Disease Models Metabolic Disease Models Non-human Primate

Virscio

US GLP AAALAC

Translational research company using Old World primate models for ophthalmology, CNS and metabolic disease studies, with an AAALAC-accredited primate facility.

In Vivo Efficacy CNS Disease Models Metabolic Disease Models Ophthalmology Models Pharmacokinetics Non-human Primate

Prisys Biotechnologies

CN GLP

Shanghai CRO centered on nonhuman primate efficacy and safety studies, with NHP disease models across metabolism, cardiovascular, renal, neurology and ophthalmology, clinical-style imaging and interventional surgery.

In Vivo Efficacy In Vivo Imaging MRI Studies PET Imaging Surgical Models Non-human Primate Cynomolgus monkey

Cynbiose

FR AAALAC

Preclinical CRO near Lyon with core expertise in nonhuman primate models, including BSL-3 infectious disease, biodistribution and custom proof-of-concept studies.

In Vivo Efficacy Biodistribution Gene Therapy Studies Infectious Disease Models Respiratory Disease Models Non-human Primate Cynomolgus monkey

Vivo Bio Tech

IN GLP

Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.

In Vivo Efficacy GLP Toxicology Pharmacokinetics Toxicology Non-human Primate Dog Mouse Rabbit

Oregon National Primate Research Center

US AAALAC

OHSU national primate research center supporting neuroscience, metabolic, reproductive and infectious disease research, with core services available to outside investigators.

In Vivo Efficacy CNS Disease Models Infectious Disease Models Metabolic Disease Models Non-human Primate Rhesus monkey

Questions to ask when choosing an In Vivo Efficacy in Non-human Primate CRO

What positive-control data do you have for this model from the past 12 months, and what is the typical effect size and variability?
How are animals randomized, and is scoring blind to treatment?
How did you choose group size for the primary endpoint?
Can PK and biomarker samples be taken from the efficacy animals?
How quickly will we see interim data, and in what format?